Back

Use of NT-proBNP in the management of Heart Failure

2 September 2019 (13:30 - 13:45)
Organised by:
Congress Presentation Part of: The role of cardiac biomarkers to aid in diagnosis and risk stratification of cardiac diseases Diagnostic Methods ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor James Januzzi

Massachusetts General Hospital - Harvard Medical School, Boston (United States of America)

2 More presentations in this session

Presentation thumbnail
Real world data from the ESC 0/1h algorithm for patients with suspected acute myocardial infraction
Doctor C. Papendick (Adelaide, AU)
Slides Video
Presentation thumbnail
Engage-AF, the role of blood-based biomarkers for the risk-prediction of atrial fibrillation patients as part of the ABC risk scores
Professor D. Morrow (Boston, US)
Slides Video

Access the full session

Session thumbnail
The role of cardiac biomarkers to aid in diagnosis and risk stratification of cardiac diseases

The Event

Event poster

ESC Congress 2019

2 September 2019 13:30 CET
You may be interested in
thumbnail
Webinar
Natriuretic peptides: role for risk prediction and treatment efficacy
7 October 2021
thumbnail
Congress Presentation
Approaches to developing a standardized screening and intervention strategy in patients with coronary artery disease and type 2 diabetes mellitus at risk of heart failure
18 May 2025
thumbnail
Congress Presentation
Cost effectiveness of heart failure investigations in a tertiary hospital in Ireland
29 June 2021
thumbnail
Congress Presentation
The role of NT ProBNP and Galectin 3 in the follow up of patients with primary mitral regurgitation
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources